Table 2.
Adverse perinatal outcomes in women with SCH.
| Outcome | SCH (n, %) | CON (n, %) | Unadjusted | Adjusted* | ||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |||
| Gestational diabetes | 25, 15.15% | 342, 11.70% | 1.30 | 0.89–1.88 | 0.18 | 1.05 | 0.0.66–1.69 | 0.84 |
| HDP | 9, 5.45% | 43, 1.47% | 3.71 | 1.84–7.48 | 0.001 | 4.04 | 1.85–8.84 | 0.000 |
| ICP | 2, 1.21% | 21, 0.72% | 1.69 | 0.40–7.13 | 0.47 | 1.72 | 0.40–7.42 | 0.47 |
| Preterm labor | 6, 3.64% | 119, 4.07% | 0.89 | 0.40–2.00 | 0.78 | 0.27 | 0.04–1.95 | 0.19 |
| Placenta previa | 9, 5.45% | 104, 3.56% | 1.53 | 0.79–2.97 | 0.21 | 1.53 | 0.76–3.09 | 0.23 |
| PROM | 37, 22.42% | 476, 16.28% | 1.38 | 1.03–1.85 | 0.04 | 1.41 | 0.96–2.05 | 0.08 |
| FGR | 0, 0.00% | 12, 0.41% | – | – | – | – | – | – |
| Fetal distress | 1, 0.61% | 16, 0.55% | 1.11 | 0.15–8.30 | 0.92 | 1.06 | 0.14–8.08 | 0.95 |
| Fetal death | 1, 0.61% | 7, 0.24% | 2.53 | 0.31–20.45 | 0.37 | 1.49 | 0.55–4.03 | 0.43 |
| Apgar < 7 | 3, 1.82% | 18, 0.62% | 2.95 | 0.88–9.92 | 0.07 | 1.76 | 0.53–5.84 | 0.35 |
| Birth weight < 2,500 g | 2, 1.21% | 80, 2.74% | 0.44 | 0.11–1.79 | 0.24 | 0.43 | 0.11–1.77 | 0.24 |
| Birth weight more than 4,000 g | 11, 6.67% | 156, 5.34% | 1.25 | 0.69–2.26 | 0.46 | 1.28 | 0.68–2.41 | 0.44 |
*
Adjusted for race. HDP, hypertensive disorders of pregnancy; ICP, intrahepatic cholestasis of pregnancy; PROM, preterm premature rupture of membranes; FGR, fetal growth restriction.